Applied Genetic Technologies (AGTC) Misses Q3 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. DASH
9. MA
10. FND

Go back to Applied Genetic Technologies (AGTC) Misses Q3 EPS by 5c

AGTC Announces Financial Results for the Third Quarter Ended March 31, 2015

May 11, 2015 4:06 PM EDT

GAINESVILLE, Fla., May 11, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, today announced financial results for the third quarter ended March 31, 2015.

"We continue to focus on our mission to develop products that transform the lives of patients with severe diseases in ophthalmology, and we are motivated by several recent and upcoming milestones," said Sue Washer, President and CEO. "Recently, the U.S. Food and Drug Administration accepted our Investigational New Drug... More